Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

Anastomosis Device Market By Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, And Surgical Adhesives), By Usability (Disposable And Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, And Others), By End-User (Hospitals & Clinics, Ambulatory Care Centres, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of cardiovascular, gastrointestinal disease, & chronic kidney diseases and the increasing technological advancements in the device

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030. The anastomosis device market is observing remarkable market growth primarily due to the increasing number of coronary bypass graft surgery (CABG) and Ileocolic anastomosis. Further, the rising prevalence of coronary disease, gastric disease, and chronic kidney disease, the increasing technological advancements in the device, the up-surging burden of elderly patients, the increasing product launches, approvals, and others will create a necessity for the anastomosis device in the market. Therefore, the market for anastomosis devices is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Anastomosis Device Market Dynamics:

One of the key factors influencing the growth of the anastomosis device in the market is the increasing prevalence of coronary heart disease across the world. According to 2023 data published by the Centers for Disease and Prevention Control (CDC), coronary heart disease is the most common type of heart disease in the US and accounted for 382,820 deaths in 2020. The key to cardiovascular disease reduction lies in the inclusion of cardiovascular disease management interventions which can be done through various surgical procedures that may involve anastomosis devices. Thus, the increasing cases of coronary heart disease will increase the number of surgical procedures which may require anastomosis devices for sealing the vessel and arteries after the surgery, ultimately increasing the use of anastomosis in cardiovascular surgery.

Further, the increasing prevalence of atherosclerosis can also increase the demand for anastomosis devices in the market. Atherosclerosis is caused by a build-up of plaque in the inner lining of an artery wall, which needs removal through surgery. The surgery may need an anastomosis device for joining both arteries in case of arteriosclerosis treatment, thus the increasing number of surgical procedures will increase the demand for anastomosis devices.

Elderly patients are more prone to various chronic diseases such as chronic kidney diseases, coronary vascular diseases, obesity, atherosclerosis, and others. For instance, the latest study conducted by Heart Research Institute concluded that over the age of 40, people in general good health have about a 50% chance of developing serious atherosclerosis, with this risk increasing with age. Most people over the age of 60 have some atherosclerosis and need surgery for removing plaque. Thus after atherosclerosis managing surgical procedure, vessels need a connection that can be made by sealants or staplers, ultimately increasing the demand for anastomosis devices.

According to the American Cancer Society 2020-2022, an estimated 104,610 new cases of colon cancer and 43,340 cases of rectal cancer were diagnosed in the US in 2020. Colon cancer may need surgery for treatment which further may need an anastomosis device for connecting the leftover vessel part of the colon to each other. Thus, the increasing prevalence of colon cancer will increase the surgical number which treats colon cancer, thereby increasing the demand for anastomosis devices.

Therefore, the factors stated above collectively will drive the overall anastomosis device market during the forecast period from 2024-2030.

However, the complications due to anastomosis, the increasing demand for minimally invasive or non-invasive treatment approaches, and others may prove to be challenging factors for anastomosis device market growth.

The anastomosis device market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitalizations and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, stroke, and others. This resulted in a reduced number of patients in hospitals or surgical centers. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of treatment devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normal life in the economic landscape initiated the process of resumption of regular healthcare services such as patient visits and surgeries for the treatment of aforementioned ailments, thereby bringing the demand for anastomosis devices on track.

Anastomosis Device Market Segment Analysis:

Anastomosis device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Ambulatory Care Centers, Hospitals and Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the anastomosis device market, the surgical staplers segment is expected to have a revenue share of XX in the year 2023. This was primarily owing to the rising focus of manufacturers towards developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.

The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.

Further, the increasing product launches and regulatory approvals of the anastomosis device will aid in increasing its demand in the market. For instance, in March 2022, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).

Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.

North America is expected to dominate the overall Anastomosis Device Market:

Among all the regions, North America is expected to hold the largest share of the anastomosis device market in 2022 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the growing government initiatives to raise effective management of coronary bypass graft surgery, the rising demand for fistula for dialysis treatment, the expanding burden of elderly patients prone to various cardiovascular disorders, the increasing prevalence of kidney diseases, increasing product launches, and the presence of advanced healthcare facilities in the region, which will boost the anastomosis market in North America during the forecast period.

For instance, as per the Centre for Disease and Prevention Control (CDC), in 2022, 20.1 million Americans aged 20 years and older were affected by coronary heart disease (CHD) 2020. Additionally, as per the same source, every year nearly about 805,000 Americans experience a heart attack. This figure of heart attack can be controlled by providing proper treatment for CHD. The treatment of CHD will need surgery in which two vessels or arteries might be requiring a closure which can be done by an anastomosis device. Thus, the increasing prevalence of CHD in the country will increase the number of surgical procedures, thereby increasing the demand for anastomosis devices in the region.

According to the United States Renal Data System 2020 Annual Data Report, nearly 786,000 people in the United States were living with end-stage renal disease (ESRD) and 71% of them were on dialysis. Dialysis patients need vascular access for dialysis therapy, this vascular access is made by the connection of artery and vein, which is called arteriovenous anastomosis. This procedure is primarily done by anastomosis devices. Thus, the increasing number of dialysis procedures will increase the number of arteriovenous anastomoses, ultimately increasing the demand for anastomosis devices. Thus, the increasing prevalence of chronic kidney disease will also increase the market for anastomosis disease in the North America region.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the anastomosis device market.

Anastomosis Device Market Key Players:

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

Recent Developmental Activities in the Anastomosis Device Market:

In February 2022, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.

In March 2022, Johnson & Johnson launched the ECHELON Stapler which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.

In April 2022, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.

In December 2020, Medtronic Private Limited announced the launch of the EEA™ Circular Stapler with Tri-Staple™ Technology. The device has three rows of varied height staples to deliver 30 percent more security to the staple line and requires 60 percent lesser firing force in the operating room as compared to current devices.

Key Takeaways from the Anastomosis Device Market Report Study

Market size analysis for current anastomosis device market size (2023), and market forecast for 6 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the anastomosis device market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global anastomosis device market.

Various opportunities are available for the other competitor in the anastomosis device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current anastomosis device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for anastomosis device market growth in the coming future?

Target Audience who can be benefited from this Anastomosis Device Market Report Study

Anastomosis devise products providers

Research organizations and consulting companies

Anastomosis device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in anastomosis device

Various end users who want to know more about the anastomosis device market and the latest technological developments in the anastomosis device market.

Frequently Asked Questions for the Anastomosis Device Market:

1. What is an anastomosis device?

The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.

2. What is the global market for anastomosis devices?

The global anastomosis device market is estimated to grow at a CAGR of 5.3% during the forecast period from 2024 to 2030.

3. What are the drivers for the global anastomosis device market?

The anastomosis device market is witnessing positive market growth owing to the factors such as the rising prevalence of coronary artery disease, arteriosclerosis, and chronic kidney disease, the growing burden of the elderly population, the increasing product launches and approvals, the presence of key players in the market, and others will create an exigency for the anastomosis device market.

4. Who are the key players operating in the global anastomosis device market?

Some of the key market players operating in the anastomosis device market include Intuitive Surgical, B. Braun SE, BAXTER, CryoLife, Inc, JOHNSON & JOHNSON, SURGIVALLEY, Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc, Hangzhou Demo Medical Technology Co., Ltd, BD., Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.

5. Which region has the highest share in the anastomosis device market?

Among all the regions, North America is estimated to amass a significant revenue share in the global anastomosis device market. This can be ascribed to the growing cases of coronary bypass graft surgery, the rising burden of elderly patients, the increasing prevalence of chronic kidney disease, the presence of advanced healthcare facilities in the region, and others that act as a supportive factor for the North America anastomosis device market growth.